Medical therapy for the overactive bladder in the elderly

被引:23
作者
Wagg, A [1 ]
Cohen, M [1 ]
机构
[1] UCL Hosp, Dept Geriatr Med, London WC1E 6AU, England
关键词
overactive bladder; pharmacotherapy; elderly;
D O I
10.1093/ageing/31.4.241
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The overactive bladder is the commonest underlying bladder disorder causing urinary incontinence in elderly people. Management of the condition relies upon a holistic assessment of the problem, lifestyle adjustment, behavioural management and drug therapy. The majority of currently available drugs rely on their anti-muscarinic properties for efficacy. Both behavioural techniques and drug therapy are effective in treatment of the elderly and each modality has a particular role to play in successful treatment and maintenance of this condition.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 50 条
[1]  
Abrams P, 1998, BRIT J UROL, V81, P801
[2]  
Abrams P, 1996, SCAND J UROL NEPHROL, V30, P47
[3]  
ABRAMS P, 1984, SCAND J UROL NEPHROL, P7
[4]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[5]   Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence [J].
Anderson, RU ;
Mobley, D ;
Blank, B ;
Saltzstein, D ;
Susset, J ;
Brown, JS .
JOURNAL OF UROLOGY, 1999, 161 (06) :1809-1812
[6]   Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine [J].
Appell, RA ;
Abrams, P ;
Drutz, HP ;
Van Kerrebroeck, PEVA ;
Millard, R ;
Wein, A .
WORLD JOURNAL OF UROLOGY, 2001, 19 (02) :141-147
[7]   A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders [J].
Bayliss, M ;
Wu, C ;
Newgreen, D ;
Mundy, AR ;
Fry, CH .
JOURNAL OF UROLOGY, 1999, 162 (05) :1833-1839
[8]   Low-dose oxybutynin for the treatment of urge incontinence: Good efficacy and few side effects [J].
Bemelmans, BLH ;
Kiemeney, LALM ;
Debruyne, FMJ .
EUROPEAN UROLOGY, 2000, 37 (06) :709-713
[9]   A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin [J].
Birns, J ;
Lukkari, E ;
Malone-Lee, JG .
BJU INTERNATIONAL, 2000, 85 (07) :793-798
[10]   CYSTOMETRIC RESPONSE TO PROPANTHELINE IN DETRUSOR HYPERREFLEXIA - THERAPEUTIC IMPLICATIONS [J].
BLAIVAS, JG ;
LABIB, KB ;
MICHALIK, SJ ;
ZAYED, AAH .
JOURNAL OF UROLOGY, 1980, 124 (02) :259-262